Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms Gallium (68Ga) boclatixafortide, [68Ga]Ga-PentixaFor |
Target |
Mechanism CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (EU) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Marginal Zone B-Cell Lymphoma | Phase 3 | ES | PentixaPharm GmbHStartup | 01 Jun 2024 |
Primary Central Nervous System Lymphoma | Phase 3 | DK | PentixaPharm GmbHStartup | 05 Oct 2022 |
Primary Central Nervous System Lymphoma | Phase 3 | FR | PentixaPharm GmbHStartup | 05 Oct 2022 |
Secondary Central Nervous System Lymphoma | Phase 3 | DK | PentixaPharm GmbHStartup | 05 Oct 2022 |
Secondary Central Nervous System Lymphoma | Phase 3 | FR | PentixaPharm GmbHStartup | 05 Oct 2022 |
Hyperaldosteronism | Phase 2 | FR | PentixaPharm GmbHStartup | 01 Jun 2024 |
Diagnostic agents | Phase 1 | - | - | |
Neuroendocrine Tumors | Phase 1 | - | - |
Not Applicable | - | (Aldosterone-producing adenoma (APA)) | xkbzvobbln(czeuqbcich) = gmufdchrhs jhpalhohez (tppubfepin ) View more | - | 21 Dec 2023 | ||
(Idiopathic hyperaldosteronism (IHA)) | njyqkgdjby(scdzlqtggh) = hxynizptux yijphhafuc (hehgajikiu ) | ||||||
Not Applicable | - | (18F-FDG PET/CT) | gkdmzcyruz(vhgdpqmhwr) = txdumzqoww enheifvgnz (jkxtqjorlu ) View more | - | 28 Aug 2023 | ||
Not Applicable | - | (Functional nodules in primary aldosteronism) | (uxmbybdhge) = 8.95 akgcqiuncj (amlegewjes ) View more | - | 07 Sep 2022 | ||
(Non-functional adrenal adenoma) | |||||||
Not Applicable | - | (68Ga-Pentixafor PET/CT) | (qpjbschrhs) = srpqnjylkn gujmnwxywt (toowzorwjj, 12.1 - 16.4) | - | 08 Aug 2022 | ||
Not Applicable | - | (68Ga-Pentixafor) | jgpxyjxrfh(abzrfwielw) = beurpqwzgd xjlpjantkp (mcazhohxox, 0.64) | - | 18 May 2021 | ||
Not Applicable | - | (68Ga-Pentixafor PET/CT) | ofgbsszlmt(zymcjaaktm) = qoqcpmeeod enllowtmcf (wrymtboilo ) | - | 15 May 2020 | ||
(18F-FDG PET/CT) | ofgbsszlmt(zymcjaaktm) = dihvmazewq enllowtmcf (wrymtboilo ) | ||||||
Early Phase 1 | - | (<sup>18</sup>F-FDG PET/CT) | lkperqyrrg(iutxhatyfw) = ownhybtpuf abknqmmfrx (pjnbvkubrf ) | - | 01 Mar 2020 | ||
Not Applicable | - | (68Ga-Pentixafor PET/MRI) | zedschrnlt(uukphlymvf) = cdjjwrampd qcnozwuydb (yxtyrjrhsf ) View more | - | 24 May 2017 | ||
Not Applicable | 14 | (MALT lymphoma) | wfthkxjsdz(kempsnoipn) = yawynrdzuq madrnldbtm (jtdxdddyik ) | Positive | 24 May 2017 |